UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004398
Receipt number R000005259
Scientific Title Open label randomized trial of treatment by perospirone and aripiprazole for schizophrenia patients considering the drug susceptibility gene
Date of disclosure of the study information 2010/10/22
Last modified on 2017/10/23 10:59:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Open label randomized trial of treatment by perospirone and aripiprazole for schizophrenia patients considering the drug susceptibility gene

Acronym

Controlled clinical comparison of perospirone and aripiprazole considering the drug susceptibility gene

Scientific Title

Open label randomized trial of treatment by perospirone and aripiprazole for schizophrenia patients considering the drug susceptibility gene

Scientific Title:Acronym

Controlled clinical comparison of perospirone and aripiprazole considering the drug susceptibility gene

Region

Japan


Condition

Condition

Schizophrenia

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To compare the therapeutic efficacy and tolerability of perospirone and aripiprazole in patients with schizophrenia considering the drug susceptibility gene.

Basic objectives2

PK,PD

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Positive and Negative Syndrome Scale
Gene polymorphism

Key secondary outcomes

Drug-Induced Extrapyramidal Symptoms Scale
Barnes Akathisia Scale
Clinical Global Impression


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Perospirone

Interventions/Control_2

Aripiprazole

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients (inpatients and outpatients) over 15 years of age, who were diagnosed with schizophrenia (according to the DSM-IV criteria) and were required to have scores PANSS total score 60 or more, and a score 4 or more on at least two of the PANSS-positive items assessing delusions, hallucinatory behavior or conceptual disorganization, were eligible. Patients for whom the total dose of antipsychotics (haloperidol equivalent dose) is lower than 12.0 mg/day at screening.

Key exclusion criteria

Patient with coma; under the depressant by barbiturates, received perospirone or aripiprazole within 4 weeks (30 days), participated in a clinical study or post-marketing clinical study within 12 months (180 days), were pregnant or may become pregnant or nursing, history of drug and alcohol abuse, neuroleptic malignant syndrome, water intoxication, known hypersensitivity to study drugs, significant risk of suicide, currently epinephrine administration precluded entry into the study, and patients considered as inadequate by investigator.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshiteru Takekita

Organization

Kansai Medical University

Division name

Department of Neuropsychiatry

Zip code


Address

10-15 fumizono-cho, Moriguchi Osaka, 570-8506, Japan

TEL

06-6992-1001

Email

takekity@takii.kmu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshiteru Takekita

Organization

Kansai Medical University

Division name

Department of Neuropsychiatry

Zip code


Address

10-15 fumizono-cho, Moriguchi Osaka, 570-8506, Japan

TEL

06-6992-1001

Homepage URL


Email

takekity@takii.kmu.ac.jp


Sponsor or person

Institute

Department of Neuropsychiatry, Kansai Medical University

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science
Dainippon Sumitomo Pharma Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Hyogo University of Health Sciences

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

関西医科大学附属滝井病院(大阪府)


Other administrative information

Date of disclosure of the study information

2010 Year 10 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2009 Year 12 Month 05 Day

Date of IRB


Anticipated trial start date

2010 Year 03 Month 01 Day

Last follow-up date

2012 Year 03 Month 01 Day

Date of closure to data entry

2012 Year 04 Month 01 Day

Date trial data considered complete

2012 Year 12 Month 01 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 10 Month 18 Day

Last modified on

2017 Year 10 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005259


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name